Morgan Stanley Portfolio holdings
Morgan Stanley, founded in 1935 by Henry Sturgis Morgan and Harold Stanley as a spin-off from J.P. Morgan & Co., is a leading global financial services firm headquartered in New York City. Initially focused on investment banking, it has evolved into a diversified powerhouse offering wealth management, institutional securities, and asset management services, catering to corporations, governments, institutions, and high-net-worth individuals. With a strong presence in mergers and acquisitions, underwriting, and trading, Morgan Stanley manages billions in assets and is known for its sophisticated financial advisory services. The firm has adapted to modern markets by expanding its digital offerings and wealth management division, notably through its 2020 acquisition of E*TRADE, solidifying its position as a Wall Street titan.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$2.77B |
| 2 |
McKesson
MCK
|
+$2.38B |
| 3 |
SPCX
SpaceX
SPCX
|
+$2.3B |
| 4 |
HONA
Honeywell Aerospace
HONA
|
+$2.05B |
| 5 |
Amazon
AMZN
|
+$1.37B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$5.96B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$3.11B |
| 3 |
Honeywell
HON
|
+$1.96B |
| 4 |
Salesforce
CRM
|
+$1.47B |
| 5 |
Vanguard FTSE Developed Markets ETF
VEA
|
+$775M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.02% |
| 2 | Technology | 24.63% |
| 3 | Financials | 9.78% |
| 4 | Healthcare | 7.32% |
| 5 | Industrials | 7.25% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
PCG.PRX
3101
PG&E Corp 6.000% Series A Preferred Stock
PCG.PRX
$1.31B
| $19.8M | ﹤0.01% |
478,779
+187,802
| +65% | +$7.85M |
|
|
ETW
3102
Eaton Vance Tax-Managed Global Buy-Write Opportunities Fund
ETW
$1.08B
| $19.8M | ﹤0.01% |
2,053,674
+77,356
| +4% | +$723K |
|
3103
Precigen
PGEN
$2.49B
| $19.8M | ﹤0.01% |
3,469,628
+1,055,306
| +44% | +$4.56M |
|
3104
National Healthcare
NHC
$3.49B
| $19.8M | ﹤0.01% |
93,536
-14,276
| -13% | -$2.62M |
|
3105
State Street SPDR Portfolio Long Term Corporate Bond ETF
SPLB
$1.22B
| $19.8M | ﹤0.01% |
882,541
-66,828
| -7% | -$1.49M |
|
3106
J&J Snack Foods
JJSF
$1.67B
| $19.7M | ﹤0.01% |
268,442
+25,302
| +10% | +$1.97M |
|
3107
iShares MSCI India Small-Cap ETF
SMIN
$772M
| $19.7M | ﹤0.01% |
278,711
+16,628
| +6% | +$1.11M |
|
3108
Asana
ASAN
$2.35B
| $19.7M | ﹤0.01% |
2,812,294
-794,744
| -22% | -$5.34M |
|
3109
Adams Diversified Equity Fund
ADX
$3.24B
| $19.6M | ﹤0.01% |
768,743
-394,528
| -34% | -$9.67M |
|
3110
Calix
CALX
$2.36B
| $19.6M | ﹤0.01% |
524,882
-187,331
| -26% | -$7.86M |
|
|
SFD
3111
Smithfield Foods
SFD
$8.64B
| $19.5M | ﹤0.01% |
805,391
-1,592,924
| -66% | -$42.6M |
|
3112
Greenlight Captial
GLRE
$502M
| $19.5M | ﹤0.01% |
1,206,347
-217,151
| -15% | -$3.73M |
|
3113
NewAmsterdam Pharma
NAMS
$3.1B
| $19.5M | ﹤0.01% |
575,825
+20,064
| +4% | +$661K |
|
3114
La-Z-Boy
LZB
$1.3B
| $19.5M | ﹤0.01% |
486,278
-55,370
| -10% | -$2M |
|
3115
Helios Technologies
HLIO
$2.41B
| $19.5M | ﹤0.01% |
218,478
+78,139
| +56% | +$6M |
|
3116
Invesco Global Listed Private Equity ETF
PSP
$248M
| $19.5M | ﹤0.01% |
349,507
+110,896
| +46% | +$6.58M |
|
3117
Oric Pharmaceuticals
ORIC
$1.37B
| $19.4M | ﹤0.01% |
1,794,020
+111,497
| +7% | +$1.01M |
|
3118
Collegium Pharmaceutical
COLL
$786M
| $19.4M | ﹤0.01% |
534,756
+19,577
| +4% | +$669K |
|
3119
First Busey Corp
BUSE
$2.5B
| $19.3M | ﹤0.01% |
655,405
+15,234
| +2% | +$413K |
|
3120
Seaboard Corp
SEB
$3.75B
| $19.3M | ﹤0.01% |
4,330
-297
| -6% | -$1.56M |
|
|
CBC
3121
Central Bancompany Inc
CBC
$7.81B
| $19.3M | ﹤0.01% |
635,900
+532,458
| +515% | +$14.5M |
|
3122
Stock Yards Bancorp
SYBT
$2.48B
| $19.3M | ﹤0.01% |
252,588
-63,805
| -20% | -$4.58M |
|
3123
VanEck Long Muni ETF
MLN
$677M
| $19.3M | ﹤0.01% |
1,083,762
+319,204
| +42% | +$5.62M |
|
3124
GMO US Quality ETF
QLTY
$5.18B
| $19.3M | ﹤0.01% |
462,955
+451,869
| +4,076% | +$18.1M |
|
3125
iShares MSCI Spain ETF
EWP
$2.24B
| $19.2M | ﹤0.01% |
323,083
+101,023
| +45% | +$5.78M |
|
Similar funds
Morgan Stanley's Q2 2026 Portfolio in Review
As of Q2 2026, Morgan Stanley held 8,715 positions worth $1.89T, up 14% from $1.66T the previous quarter. Its ten largest holdings account for 21% of the portfolio.
Morgan Stanley's Q2 2026 filing shows 423 new, 3,809 increased, 3,216 reduced and 305 closed positions. Its largest new stake was SpaceX: 13,532,773 shares worth $2.31B. The largest sale was State Street SPDR S&P 500 ETF Trust, an estimated $5.96B.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, down from 27% a quarter earlier, followed by Technology and Financials.
- Morgan Stanley's largest Q2 2026 buy was SpaceX: 13,532,773 shares worth $2.31B.
- Morgan Stanley added most to NVIDIA in Q2 2026, an estimated $2.77B increase.
- Morgan Stanley's biggest Q2 2026 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $5.96B.
- Morgan Stanley fully exited Apellis Pharmaceuticals in Q2 2026, selling an estimated $404M.
- Morgan Stanley's ten largest holdings make up 21% of its $1.89T portfolio in Q2 2026.
- Morgan Stanley opened 423 new positions and closed 305 in Q2 2026.
- Morgan Stanley's portfolio value rose 14% quarter-over-quarter to $1.89T.
Based on Morgan Stanley's 13F filing for Q2 2026, filed 13 Aug 2026.